Exceptionally low likelihood of Alzheimer’s dementia in APOE2 homozygotes from a 5,000-person neuropathological study DOI Creative Commons
Eric M. Reiman, Joseph F. Arboleda‐Velásquez, Yakeel T. Quiroz

et al.

Nature Communications, Journal Year: 2020, Volume and Issue: 11(1)

Published: Feb. 3, 2020

Each additional copy of the apolipoprotein E4 (APOE4) allele is associated with a higher risk Alzheimer's dementia, while APOE2 lower it not yet known whether homozygotes have particularly low risk. We generated dementia odds ratios and other findings in more than 5,000 clinically characterized neuropathologically cases controls. APOE2/2 was compared to APOE2/3 3/3, an exceptionally ratio APOE4/4, impact APOE4 gene dose significantly greater confirmed group 24,000 unconfirmed Finding targeting factors by which APOE its variants influence disease could major on understanding, treatment prevention disease.

Language: Английский

Heart Disease and Stroke Statistics—2023 Update: A Report From the American Heart Association DOI Creative Commons

Connie W. Tsao,

Aaron W. Aday, Zaid Almarzooq

et al.

Circulation, Journal Year: 2023, Volume and Issue: 147(8)

Published: Jan. 25, 2023

Background: The American Heart Association, in conjunction with the National Institutes of Health, annually reports most up-to-date statistics related to heart disease, stroke, and cardiovascular risk factors, including core health behaviors (smoking, physical activity, diet, weight) factors (cholesterol, blood pressure, glucose control) that contribute health. Statistical Update presents latest data on a range major clinical circulatory disease conditions (including congenital rhythm disorders, subclinical atherosclerosis, coronary failure, valvular venous peripheral artery disease) associated outcomes quality care, procedures, economic costs). Methods: through its Epidemiology Prevention Statistics Committee, continuously monitors evaluates sources stroke United States provide current information available annual review published literature year before writing. 2023 is product full year’s worth effort 2022 by dedicated volunteer clinicians scientists, committed government professionals, Association staff members. strives further understand help heal problems inflicted structural racism, public crisis can significantly damage mental perpetuate disparities access education, income, housing, several other vital healthy lives. This edition includes additional COVID-19 (coronavirus 2019) publications, as well monitoring benefits population, an enhanced focus equity across key domains. Results: Each chapters focuses different topic statistics. Conclusions: represents critical resource for lay public, policymakers, media clinicians, care administrators, researchers, advocates, others seeking best these conditions.

Language: Английский

Citations

4232

Alzheimer Disease: An Update on Pathobiology and Treatment Strategies DOI Creative Commons
Justin M. Long, David M. Holtzman

Cell, Journal Year: 2019, Volume and Issue: 179(2), P. 312 - 339

Published: Sept. 26, 2019

Language: Английский

Citations

2351

Alzheimer disease DOI
David S. Knopman, Hélène Amieva, Ronald C. Petersen

et al.

Nature Reviews Disease Primers, Journal Year: 2021, Volume and Issue: 7(1)

Published: May 13, 2021

Language: Английский

Citations

1503

New insights into the genetic etiology of Alzheimer’s disease and related dementias DOI Creative Commons
Céline Bellenguez, Fahri Küçükali, Iris E. Jansen

et al.

Nature Genetics, Journal Year: 2022, Volume and Issue: 54(4), P. 412 - 436

Published: April 1, 2022

Abstract Characterization of the genetic landscape Alzheimer’s disease (AD) and related dementias (ADD) provides a unique opportunity for better understanding associated pathophysiological processes. We performed two-stage genome-wide association study totaling 111,326 clinically diagnosed/‘proxy’ AD cases 677,663 controls. found 75 risk loci, which 42 were new at time analysis. Pathway enrichment analyses confirmed involvement amyloid/tau pathways highlighted microglia implication. Gene prioritization in loci identified 31 genes that suggestive genetically processes, including tumor necrosis factor alpha pathway through linear ubiquitin chain assembly complex. also built score with future AD/dementia or progression from mild cognitive impairment to AD/dementia. The improvement prediction led 1.6- 1.9-fold increase lowest highest decile, addition effects age APOE ε4 allele.

Language: Английский

Citations

1500

Tutorial: a guide to performing polygenic risk score analyses DOI
Shing Wan Choi, Timothy Shin Heng Mak, Paul F. O’Reilly

et al.

Nature Protocols, Journal Year: 2020, Volume and Issue: 15(9), P. 2759 - 2772

Published: July 24, 2020

Language: Английский

Citations

1422

The Amyloid-β Pathway in Alzheimer’s Disease DOI Creative Commons
Harald Hampel, John Hardy, Kaj Blennow

et al.

Molecular Psychiatry, Journal Year: 2021, Volume and Issue: 26(10), P. 5481 - 5503

Published: Aug. 30, 2021

Abstract Breakthroughs in molecular medicine have positioned the amyloid-β (Aβ) pathway at center of Alzheimer’s disease (AD) pathophysiology. While detailed mechanisms and spatial-temporal dynamics leading to synaptic failure, neurodegeneration, clinical onset are still under intense investigation, established biochemical alterations Aβ cycle remain core biological hallmark AD promising targets for development disease-modifying therapies. Here, we systematically review update vast state-of-the-art literature science with evidence from basic research studies human genetic multi-modal biomarker investigations, which supports a crucial role dyshomeostasis pathophysiological dynamics. We discuss highlighting differentiated interaction distinct species other AD-related mechanisms, such as tau-mediated, neuroimmune inflammatory changes, well neurochemical imbalance. Through lens latest multimodal vivo biomarkers AD, this cross-disciplinary examines compelling hypothesis- data-driven rationale Aβ-targeting therapeutic strategies early treatment AD.

Language: Английский

Citations

1041

2024 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association DOI Creative Commons
Seth S. Martin, Aaron W. Aday, Zaid Almarzooq

et al.

Circulation, Journal Year: 2024, Volume and Issue: 149(8)

Published: Jan. 24, 2024

BACKGROUND: The American Heart Association (AHA), in conjunction with the National Institutes of Health, annually reports most up-to-date statistics related to heart disease, stroke, and cardiovascular risk factors, including core health behaviors (smoking, physical activity, nutrition, sleep, obesity) factors (cholesterol, blood pressure, glucose control, metabolic syndrome) that contribute health. AHA Disease Stroke Statistical Update presents latest data on a range major clinical circulatory disease conditions (including brain health, complications pregnancy, kidney congenital rhythm disorders, sudden cardiac arrest, subclinical atherosclerosis, coronary cardiomyopathy, failure, valvular venous thromboembolism, peripheral artery disease) associated outcomes quality care, procedures, economic costs). METHODS: AHA, through its Epidemiology Prevention Statistics Committee, continuously monitors evaluates sources stroke United States globally provide current information available annual review published literature year before writing. 2024 is product full year’s worth effort 2023 by dedicated volunteer clinicians scientists, committed government professionals, staff members. strives further understand help heal problems inflicted structural racism, public crisis can significantly damage mental perpetuate disparities access education, income, housing, several other vital healthy lives. This edition includes additional global data, as well monitoring benefits population, an enhanced focus equity across key domains. RESULTS: Each chapters focuses different topic statistics. CONCLUSIONS: represents critical resource for lay public, policymakers, media clinicians, care administrators, researchers, advocates, others seeking best these conditions.

Language: Английский

Citations

914

A genome-wide association study with 1,126,563 individuals identifies new risk loci for Alzheimer’s disease DOI
Douglas P. Wightman, Iris E. Jansen, Jeanne E. Savage

et al.

Nature Genetics, Journal Year: 2021, Volume and Issue: 53(9), P. 1276 - 1282

Published: Sept. 1, 2021

Language: Английский

Citations

717

Clinical diagnosis of Alzheimer's disease: recommendations of the International Working Group DOI

Bruno Dubois,

Nicolas Villain, Giovanni B. Frisoni

et al.

The Lancet Neurology, Journal Year: 2021, Volume and Issue: 20(6), P. 484 - 496

Published: April 30, 2021

Language: Английский

Citations

690

APOE and Alzheimer's disease: advances in genetics, pathophysiology, and therapeutic approaches DOI
Alberto Serrano‐Pozo, Sudeshna Das, Bradley T. Hyman

et al.

The Lancet Neurology, Journal Year: 2020, Volume and Issue: 20(1), P. 68 - 80

Published: Dec. 17, 2020

Language: Английский

Citations

652